Home / Drug shortages / Lisdexamfetamine Dimesylate Capsule

Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Rhodes Pharmaceuticals L.P.

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Rhodes Pharmaceuticals L.P. with status Current. The shortage was first posted on 07/14/2023. Reported reason: Shortage of an active ingredient

Shortage Details

Status
Current
Company
Rhodes Pharmaceuticals L.P.
Package NDC
42858-164-01
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01)
Initial Posting
07/14/2023
Revised Date

Reason

Shortage of an active ingredient

FDA data resources